[Lani]

1: Sarwar N, Kim JS, Jiang J, Peston D, Sinnett HD, Madden P, Gee JM, Nicholson RI, Lykkesfeldt AE, Shousha S, Coombes RC, Ali S. Related Articles, Links
Phosphorylation of ER{alpha} at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ER{alpha} phosphorylation in breast cancer progression.
Endocr Relat Cancer. 2006 Sep;13(3):851-61.
PMID: 16954434 [PubMed - in process]
2: Jones HE, Gee JM, Barrow D, Tonge D, Holloway B, Nicholson RI. Related Articles, Links
Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells.
Br J Cancer. 2006 Jul 17;95(2):172-80. Epub 2006 Jul 4.
PMID: 16819546 [PubMed - in process]
3: Cui Y, Parra I, Zhang M, Hilsenbeck SG, Tsimelzon A, Furukawa T, Horii A, Zhang ZY, Nicholson RI, Fuqua SA. Related Articles, Links
Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance.
Cancer Res. 2006 Jun 1;66(11):5950-9.
PMID: 16740736 [PubMed - indexed for MEDLINE]
4: De Martino G, Edler MC, La Regina G, Coluccia A, Barbera MC, Barrow D, Nicholson RI, Chiosis G, Brancale A, Hamel E, Artico M, Silvestri R. Related Articles, Links
New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies.
J Med Chem. 2006 Feb 9;49(3):947-54.
PMID: 16451061 [PubMed - indexed for MEDLINE]
5: Hiscox S, Morgan L, Green TP, Barrow D, Gee J, Nicholson RI. Related Articles, Links
Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.
Breast Cancer Res Treat. 2006 Jun;97(3):263-74. Epub 2005 Dec 7.
PMID: 16333527 [PubMed - in process]
6: Greco F, Vicent MJ, Penning NA, Nicholson RI, Duncan R. Related Articles, Links
HPMA copolymer-aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines.
J Drug Target. 2005 Sep-Nov;13(8-9):459-70.
PMID: 16332571 [PubMed - indexed for MEDLINE]
7: Yee SW, Jarno L, Gomaa MS, Elford C, Ooi LL, Coogan MP, McClelland R, Nicholson RI, Evans BA, Brancale A, Simons C. Related Articles, Links
Novel tetralone-derived retinoic acid metabolism blocking agents: synthesis and in vitro evaluation with liver microsomal and MCF-7 CYP26A1 cell assays.
J Med Chem. 2005 Nov 17;48(23):7123-31.
PMID: 16279770 [PubMed - indexed for MEDLINE]
8: Britton DJ, Hutcheson IR, Knowlden JM, Barrow D, Giles M, McClelland RA, Gee JM, Nicholson RI. Related Articles, Links
Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth.
Breast Cancer Res Treat. 2006 Mar;96(2):131-46. Epub 2005 Oct 27.
PMID: 16261397 [PubMed - in process]
9: Dowsett M, Nicholson RI, Pietras RJ. Related Articles, Links
Biological characteristics of the pure antiestrogen fulvestrant: overcoming endocrine resistance.
Breast Cancer Res Treat. 2005;93 Suppl 1:S11-8. Review.
PMID: 16247595 [PubMed - indexed for MEDLINE]
10: Nicholson RI, Johnston SR. Related Articles, Links
Endocrine therapy--current benefits and limitations.
Breast Cancer Res Treat. 2005;93 Suppl 1:S3-10. Review.
PMID: 16247594 [PubMed - indexed for MEDLINE]
11: Rampaul RS, Pinder SE, Nicholson RI, Gullick WJ, Robertson JF, Ellis IO. Related Articles, Links
Clinical value of epidermal growth factor receptor expression in primary breast cancer.
Adv Anat Pathol. 2005 Sep;12(5):271-3. Review.
PMID: 16210923 [PubMed - indexed for MEDLINE]
12: Gee JM, Robertson JF, Gutteridge E, Ellis IO, Pinder SE, Rubini M, Nicholson RI. Related Articles, Links
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer.
Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S99-S111. Review.
PMID: 16113104 [PubMed - indexed for MEDLINE]
13: Staka CM, Nicholson RI, Gee JM. Related Articles, Links
Acquired resistance to oestrogen deprivation: role for growth factor signalling kinases/oestrogen receptor cross-talk revealed in new MCF-7X model.
Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S85-97.
PMID: 16113102 [PubMed - indexed for MEDLINE]
14: Nicholson RI, Hutcheson IR, Hiscox SE, Knowlden JM, Giles M, Barrow D, Gee JM. Related Articles, Links
Growth factor signalling and resistance to selective oestrogen receptor modulators and pure anti-oestrogens: the use of anti-growth factor therapies to treat or delay endocrine resistance in breast cancer.
Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S29-36. Review.
PMID: 16113097 [PubMed - indexed for MEDLINE]
15: Duncan R, Vicent MJ, Greco F, Nicholson RI. Related Articles, Links
Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer.
Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S189-99. Review.
PMID: 16113096 [PubMed - indexed for MEDLINE]
16: Jones HE, Gee JM, Taylor KM, Barrow D, Williams HD, Rubini M, Nicholson RI. Related Articles, Links
Development of strategies for the use of anti-growth factor treatments.
Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S173-82. Review.
PMID: 16113094 [PubMed - indexed for MEDLINE]
17: Agrawal A, Gutteridge E, Gee JM, Nicholson RI, Robertson JF. Related Articles, Links
Overview of tyrosine kinase inhibitors in clinical breast cancer.
Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S135-44. Review.
PMID: 16113090 [PubMed - indexed for MEDLINE]
18: Gee JM, Howell A, Gullick WJ, Benz CC, Sutherland RL, Santen RJ, Martin LA, Ciardiello F, Miller WR, Dowsett M, Barrett-Lee P, Robertson JF, Johnston SR, Jones HE, Wakeling AE, Duncan R, Nicholson RI. Related Articles, Links
Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment.
Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S1-7. Review.
PMID: 16113086 [PubMed - indexed for MEDLINE]
19: Hiscox S, Jiang WG, Obermeier K, Taylor K, Morgan L, Burmi R, Barrow D, Nicholson RI. Related Articles, Links
Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation.
Int J Cancer. 2006 Jan 15;118(2):290-301.
PMID: 16080193 [PubMed - indexed for MEDLINE]
20: Knowlden JM, Hutcheson IR, Barrow D, Gee JM, Nicholson RI. Related Articles, Links
Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
Endocrinology. 2005 Nov;146(11):4609-18. Epub 2005 Jul 21.
PMID: 16037379 [PubMed - indexed for MEDLINE]
Items 1 - 20 of 211

Hope this helps!